About 34 Trademarks found that are owned by LaboratoIre Francais Du Fractionnement Et Des Biotechnologies

Anti-CD20 recombinant monoclonal antibody for medical use

"USA"

The mark consists of three co-linear rectangles, with the left rectangle being gray, the middle rectangle being red, and the right rectangle being blue. The letters "LFB" are gray and are positioned to the right of the three rectangles. The letter "B" in "LFB" is italicized. The word "PLASMA" is gray and is positioned immediately beneath the letters "LFB".

Custom manufacture of pharmaceuticals, biosimilars, biopharmaceutical and veterinary preparations and proteins for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases

"USA"

SEVEN FACT

Scientific and technological services, namely, laboratory research relating to the design of new pharmaceutical products and therapeutic protein-based medicines for others; design and development of new pharmaceutical products and therapeutic protein-based medicines for others utilizing recombinant DNA technologies; consulting services in the fields of pharmaceutical research and development, including therapeutic protein-based pharmaceutical research and development, and laboratory testing, diagnostics and pharmacogenetics related thereto; engineering; scientific laboratory services utilizing computer software platforms and recombinant DNA technologies for the development and optimization of pharmaceutical products, including therapeutic protein-based medicines, and laboratory analysis and laboratory research related thereto

Editing and publishing of texts other than advertising texts in the field of health; arranging and providing education, training and instruction, namely, providing classes, seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops in the field of health; organization and conducting of seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops, in the field of health

Scientific apparatus and instruments, namely, diagnostic apparatus and instruments for calculating and managing drug penetration parameters, for assessing immune deficiency, for laboratory use; downloadable electronic and digital publications, namely, magazines, newsletters, brochures, articles in the field of health; downloadable instructional and teaching material, namely, software in the field of health; electronic reports featuring results from clinical trials and studies in the field of health; recorded software, namely, software for providing medical information in the field of immunology, haemostasis, intensive care, immune deficiency; computer software for educational and commercial activities, namely, software providing information in the field of health; software applications used with medical diagnostic apparatus to calculate and manage immune deficiency or bleeding; computer software for Websites, Intranet and the Internet, namely, software for training and information of patients and health professionals; downloadable computer software applications in the field of health for calculating and managing drug penetration parameters in the human body

Pharmaceutical products and preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; medicines for cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; protein supplements; diagnostic kits consisting primarily of monoclonal antibodies and fragment crystallizable proteins, buffers, and reagents for use in disease testing

Scientific and technological services, namely, scientific research and analysis in the field of monoclonal antibodies and fragment crystallizable proteins; design and development of medical products, namely, pharmaceutical compositions of monoclonal antibodies and fragment crystallizable proteins; scientific study and research in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; research and development in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; cellular and molecular biological research; testing, inspection or research of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; consulting in the field of medical research; engineering; genetic engineering; scientific research services using protein expression platform technology for research and development of pharmaceuticals; scientific research services using protein expression platform technology for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; scientific laboratory services in the field of monoclonal antibodies

Pharmaceutical products for treating inflammatory diseases of the digestive tract

The mark consists of a design of two blue vertical curved bands and one grey curved band at the top forming the shape of a letter "Y" with a shaded red circle at the top and the wording "YMUNEO" in a gray stylized font to the right. The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.

Downloadable computer software for training and informing health professionals and patients in the field of immune deficiencies; downloadable software for use in database management in the field of immune deficiencies; data processing equipment, namely, equipment for processing data relating to the calculation of the development and level of immune deficiency; downloadable electronic and digital publications in the nature of brochures, booklets and teaching materials in the field of immune deficiencies; downloadable computer application software and web applications, namely, software for use in database management and use in electronic storage of data in the field of immune deficiencies